# Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)

> **NCT00428792** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 150 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate 20 mg long-acting capsules

## Key facts

- **NCT ID:** NCT00428792
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2011-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00428792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00428792, "Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00428792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*